Management of human cytomegalovirus infection in transplant recipients by the pre-emptive therapy approach

Author： Gerna Giuseppe   Baldanti Fausto   Lilleri Daniele  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.4, Iss.2, 2009-03, pp. : 155-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Management Strategies for the Prevention and Treatment of Cytomegalovirus Infection in Pediatric Transplant Recipients

By Bueno J.  

Pediatric Drugs, Vol. 4, Iss. 5, 2002-01 ,pp. : 279-290

Adis International

Access to resources Recommend Favorite

Monitoring of Human Cytomegalovirus Infection in Bone Marrow and Liver Transplant Recipients by Antigenaemia Assay and Enzyme-linked Immunosorbent Assay

By Zhang X   Fan J   Yang MF   Chen XM   Gao HN   Zhao H   Ma WH   Li LJ  

The Journal of International Medical Research, Vol. 37, Iss. 1, 2009-01 ,pp. : 31-36

Field House Publishing

Access to resources Recommend Favorite

Pre-emptive ganciclovir preferred for CMV disease after kidney transplant

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 273, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Ganciclovir: An Update of its Use in the Prevention of Cytomegalovirus Infection and Disease in Transplant Recipients

By McGavin J.K.   Goa K.L.  

Drugs, Vol. 61, Iss. 8, 2001-01 ,pp. : 1153-1183

Adis International

Access to resources Recommend Favorite

Ganciclovir: An Update of its Use in the Prevention of Cytomegalovirus Infection and Disease in Transplant Recipients

By Noble S.   Faulds D.  

Drugs, Vol. 56, Iss. 1, 1998-07 ,pp. : 115-146

Adis International

Access to resources Recommend Favorite